NYSE: HQH - Tekla Healthcare Investors

Rentabilität für sechs Monate: +17.06%
Sektor: Financials

Aktionsplan Tekla Healthcare Investors

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.

Weitere Details
It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Выручка -0.1436
EBITDA -0.1424
Число акций ао 0.04944 млрд
P/E 3.72
P/S -5.44
P/BV 0.896
EV/EBITDA -5.47
Цена ао 16.69
Сайт https://www.teklacap.com/hqh.html
Див.доход ао 10.59
Дивиденд ао 1.07
Валюта usd
ISIN US87911J1034
IPO date 1988-01-05
Sector Financials
Industry Capital Markets
Валюта отчета usd
Preisänderung pro Tag: 0% (18.53)
Preisänderung pro Woche: +1.09% (18.33)
Preisänderung pro Monat: -2.22% (18.95)
Preisänderung über 3 Monate: +0.5426% (18.43)
Preisänderung über sechs Monate: +17.06% (15.83)
Preisänderung pro Jahr: +21.43% (15.26)
Preisänderung über 3 Jahre: -25.22% (24.78)
Preisänderung über 5 Jahre: -1.65% (18.84)
Preisänderung seit Jahresbeginn: +24.45% (14.89)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 13.27 1
P/BV 0.8282 9
P/E 13.69 8
EV/EBITDA 13.69 7
Gesamt: 7.63

Effizienz

Name Bedeutung Grad
ROA, % 6.04 2
ROE, % 6.05 2
Gesamt: 4.33

Dividenden

Name Bedeutung Grad
Div yield, % 10.3 10
DSI 0.8571 8.57
Gesamt: 6.4

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -140.47 0
Rentabilität Ebitda, % -138.77 0
Rentabilität EPS, % -132.28 0
Gesamt: 0
Weitere Details

Institutionen Volumen Aktie, %
Morgan Stanley 3021776 6.25
Saba Capital Management, L.P. 1424346 2.95
Cornerstone Advisors, LLC 732299 1.51
AQR Arbitrage LLC 500418 1.03
Royal Bank of Canada 469916 0.97
RPO LLC 382486 0.79
Clough Capital Partners, LP 323228 0.67
BOOTHBAY FUND MANAGEMENT, LLC 312251 0.65
Logan Stone Capital, LLC 297287 0.61
Eschler Asset Management LLP 263560 0.55

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
First Trust Income Opportunities ETF 3.34939 22.396345594824 2.48805
Saba Closed End Funds ETF 2.13068 28.094415659182 2.29022
Amplify High Income ETF 3.10824 10.326086956522 2.77149



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager N/A 1953 (71 Jahr)
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager N/A
Mr. Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager N/A
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager N/A 1962 (62 Jahr)

Adresse: United States, Boston. MA, 100 Federal Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.teklacap.com/hqh.html